DK1572233T3 - Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 - Google Patents

Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Info

Publication number: DK1572233T3
Authority: DK; Denmark
Prior art keywords: hpv18; hpv16; types; vaccine against; oncogenic hpv
Prior art date: 2002-12-20

Application number

DK03789346.8T

Other languages

Danish (da)

English (en)

Inventor

Gary Dubin

Bruce Innis

M A C Wettendorff

Moncef M Slaoui

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2003-12-18

Publication date

2011-06-27

2003-12-18 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2011-06-27 Application granted granted Critical

2011-06-27 Publication of DK1572233T3 publication Critical patent/DK1572233T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK03789346.8T 2002-12-20 2003-12-18 Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 DK1572233T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US43503502P	2002-12-20	2002-12-20
US49665303P	2003-08-20	2003-08-20
PCT/EP2003/014562 WO2004056389A1 (en)	2002-12-20	2003-12-18	Hpv-16 and -18 l1 vlp vaccine

Publications (1)

Publication Number	Publication Date
DK1572233T3 true DK1572233T3 (da)	2011-06-27

Family

ID=32685362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03789346.8T DK1572233T3 (da)	2002-12-20	2003-12-18	Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Country Status (28)

Country	Link
US (2)	US20060251676A1 (2)
EP (1)	EP1572233B1 (2)
JP (1)	JP5475939B2 (2)
KR (3)	KR101361769B1 (2)
AP (1)	AP2005003347A0 (2)
AR (1)	AR042530A1 (2)
AT (1)	ATE503492T1 (2)
AU (1)	AU2003293942B2 (2)
BE (3)	BE2015C068I2 (2)
BR (1)	BR0317544A (2)
CA (1)	CA2510457C (2)
CY (1)	CY1111552T1 (2)
DE (1)	DE60336581D1 (2)
DK (1)	DK1572233T3 (2)
EA (2)	EA200701633A1 (2)
EC (1)	ECSP055869A (2)
IL (1)	IL169085A (2)
IS (1)	IS2811B (2)
MA (1)	MA27581A1 (2)
MX (1)	MXPA05006764A (2)
MY (1)	MY144492A (2)
NO (1)	NO20052846L (2)
NZ (1)	NZ540811A (2)
OA (1)	OA13147A (2)
PL (1)	PL215257B1 (2)
PT (1)	PT1572233E (2)
TW (1)	TWI349557B (2)
WO (1)	WO2004056389A1 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69935606T9 (de)	1998-10-16	2021-03-11	Glaxosmithkline Biologicals S.A.	Adjuvanzsysteme und impfstoffe
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US7858098B2 (en)	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
PE20060434A1 (es) *	2004-06-16	2006-06-08	Glaxosmithkline Biolog Sa	Composicion inmunogenica que comprende plv o capsomeros de vph 16, vph 18 y al menos otro tipo de cancer de vph
US7758866B2 (en) *	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
AU2006236905B2 (en)	2005-04-15	2010-06-03	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
CA2606092A1 (en) *	2005-04-26	2006-11-02	Glaxosmithkline Biologicals S.A.	Vaccine
AR053715A1 (es) *	2005-04-26	2007-05-16	Glaxosmithkline Biolog Sa	Vacuna multivalente de vph
US9364529B2 (en)	2007-04-29	2016-06-14	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	Truncated L1 protein of human papillomavirus type 18
US9428555B2 (en)	2007-04-29	2016-08-30	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	Truncated L1 protein of Human Papillomavirus type 16
EP2403507B1 (en) *	2009-03-05	2018-02-21	McCloskey, Jenny Colleen	Treatment of infection
US9566323B2 (en) *	2009-06-19	2017-02-14	Eyegene Inc.	Vaccine for cervical cancer
US20170212116A1 (en)	2014-01-31	2017-07-27	Ulisse Biomed Srl	Biosensors for the detection of infection and associated maladies
CN107001430A (zh)	2014-10-24	2017-08-01	哈普威克斯有限责任公司	癌症和皮肤病变治疗
US10799574B2 (en)	2014-10-24	2020-10-13	Hpvvax. Llc	Method and composition for treating cancer or skin lesion using a vaccine
US20180153985A1 (en) *	2015-06-02	2018-06-07	Terumo Kabushiki Kaisha	Adjuvant composition containing aluminum and vaccine composition containing the same
IL277128B2 (en)	2018-03-06	2025-11-01	Precigen Inc	Hepatitis b vaccines and uses of the same
WO2019173465A1 (en) *	2018-03-06	2019-09-12	Intrexon Corporation	Human papillomavirus vaccines and uses of the same
BR112020024699A2 (pt) *	2018-06-04	2021-03-09	Xiamen University	Mutante da proteína l1 do papilomavírus humano tipo 18
WO2020117715A1 (en)	2018-12-03	2020-06-11	Board Of Regents, The University Of Texas System	Oligo-benzamide analogs and their use in cancer treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332596A1 (de) *	1993-09-24	1995-03-30	Martin Josef Dr Sapp	Monoklonale Antikörper
ES2572628T3 (es)	1997-09-05	2016-06-01	Medimmune, Inc.	Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
DE60040727D1 (de) *	1999-02-05	2008-12-18	Merck & Co Inc	Menschliche papillomavirus impfstoff-formulierungen
US6245568B1 (en)	1999-03-26	2001-06-12	Merck & Co., Inc.	Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
US6908613B2 (en) *	2000-06-21	2005-06-21	Medimmune, Inc.	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
DK1296711T3 (da) *	2000-06-26	2006-08-28	Stressgen Biotechnologies Corp	HPV-E7 til behandling af humant papillomavirus

2003
- 2003-12-18 WO PCT/EP2003/014562 patent/WO2004056389A1/en not_active Ceased
- 2003-12-18 US US10/540,099 patent/US20060251676A1/en not_active Abandoned
- 2003-12-18 PT PT03789346T patent/PT1572233E/pt unknown
- 2003-12-18 JP JP2005502554A patent/JP5475939B2/ja not_active Expired - Lifetime
- 2003-12-18 KR KR1020127027784A patent/KR101361769B1/ko not_active Expired - Lifetime
- 2003-12-18 KR KR1020127026719A patent/KR20120118087A/ko not_active Withdrawn
- 2003-12-18 EA EA200701633A patent/EA200701633A1/ru unknown
- 2003-12-18 NZ NZ540811A patent/NZ540811A/en not_active IP Right Cessation
- 2003-12-18 CA CA2510457A patent/CA2510457C/en not_active Expired - Lifetime
- 2003-12-18 TW TW092135963A patent/TWI349557B/zh not_active IP Right Cessation
- 2003-12-18 PL PL377710A patent/PL215257B1/pl unknown
- 2003-12-18 AR ARP030104709A patent/AR042530A1/es unknown
- 2003-12-18 EA EA200500834A patent/EA009179B1/ru not_active IP Right Cessation
- 2003-12-18 AU AU2003293942A patent/AU2003293942B2/en not_active Expired
- 2003-12-18 DE DE60336581T patent/DE60336581D1/de not_active Expired - Lifetime
- 2003-12-18 OA OA1200500189A patent/OA13147A/en unknown
- 2003-12-18 BR BR0317544-8A patent/BR0317544A/pt not_active Application Discontinuation
- 2003-12-18 MX MXPA05006764A patent/MXPA05006764A/es active IP Right Grant
- 2003-12-18 EP EP03789346A patent/EP1572233B1/en not_active Expired - Lifetime
- 2003-12-18 AP AP2005003347A patent/AP2005003347A0/xx unknown
- 2003-12-18 KR KR1020057011497A patent/KR20050086924A/ko not_active Ceased
- 2003-12-18 AT AT03789346T patent/ATE503492T1/de active
- 2003-12-18 DK DK03789346.8T patent/DK1572233T3/da active
- 2003-12-18 MY MYPI20034868A patent/MY144492A/en unknown
2005
- 2005-04-26 US US11/114,301 patent/US20050287161A1/en not_active Abandoned
- 2005-06-09 IL IL169085A patent/IL169085A/en active IP Right Grant
- 2005-06-09 IS IS7885A patent/IS2811B/is unknown
- 2005-06-13 NO NO20052846A patent/NO20052846L/no not_active Application Discontinuation
- 2005-06-20 EC EC2005005869A patent/ECSP055869A/es unknown
- 2005-07-18 MA MA28398A patent/MA27581A1/fr unknown
2011
- 2011-06-08 CY CY20111100549T patent/CY1111552T1/el unknown
2015
- 2015-12-09 BE BE2015C068C patent/BE2015C068I2/fr unknown
- 2015-12-09 BE BE2015C069C patent/BE2015C069I2/fr unknown
- 2015-12-09 BE BE2015C067C patent/BE2015C067I2/fr unknown

Also Published As

Publication number	Publication date
KR20120123616A (ko)	2012-11-08
EP1572233A1 (en)	2005-09-14
KR20120118087A (ko)	2012-10-25
MXPA05006764A (es)	2005-09-08
EP1572233B1 (en)	2011-03-30
JP5475939B2 (ja)	2014-04-16
IS2811B (is)	2012-11-15
CA2510457A1 (en)	2004-07-08
HK1085378A1 (en)	2006-08-25
DE60336581D1 (de)	2011-05-12
BE2015C069I2 (2)	2024-08-08
AU2003293942A1 (en)	2004-07-14
NO20052846L (no)	2005-07-13
CY1111552T1 (el)	2015-08-05
IL169085A (en)	2014-04-30
EA200701633A1 (ru)	2007-12-28
NZ540811A (en)	2007-03-30
EA200500834A1 (ru)	2006-02-24
US20050287161A1 (en)	2005-12-29
ATE503492T1 (de)	2011-04-15
TW200423957A (en)	2004-11-16
KR20050086924A (ko)	2005-08-30
US20060251676A1 (en)	2006-11-09
IS7885A (is)	2005-06-09
AP2005003347A0 (en)	2005-06-30
PL215257B1 (pl)	2013-11-29
OA13147A (en)	2006-12-13
CA2510457C (en)	2011-12-06
WO2004056389A1 (en)	2004-07-08
MY144492A (en)	2011-09-30
ECSP055869A (es)	2005-09-20
BE2015C067I2 (2)	2024-08-08
JP2006512413A (ja)	2006-04-13
KR101361769B1 (ko)	2014-02-10
AU2003293942B2 (en)	2009-12-10
PT1572233E (pt)	2011-06-07
EA009179B1 (ru)	2007-12-28
TWI349557B (en)	2011-10-01
BE2015C068I2 (2)	2024-08-08
AR042530A1 (es)	2005-06-22
MA27581A1 (fr)	2005-10-03
IL169085A0 (en)	2007-07-04
PL377710A1 (pl)	2006-02-06
BR0317544A (pt)	2005-11-22

Publication	Publication Date	Title
DK1572233T3 (da)	2011-06-27	Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
ATE312624T1 (de)	2005-12-15	Impfstoff gegen hpv
ECSP045300A (es)	2005-01-03	Antígenos virales
DE60040727D1 (de)	2008-12-18	Menschliche papillomavirus impfstoff-formulierungen
DE60329367D1 (de)	2009-11-05	Verwendung bei der bekämpfung von hepatitis c virusinfektion
CY2016018I1 (el)	2016-12-14	Εμβολιο κατα του ιου του δυτικου νειλου
HUS1500060I1 (hu)	2017-10-30	A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina
IS7830A (is)	2005-04-28	Bóluefni gegn lifrarbólgu C veiru (HCV)
DK1303265T3 (da)	2007-11-12	Anvendelse af COX-2-inhibitorer, som immunostimulerende midler ved behandling af HIV eller AIDS
EP1723238A4 (en)	2007-07-04	MODIFIED ONCOLYTIC VIRUSES
ATE455124T1 (de)	2010-01-15	Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
ATE392903T1 (de)	2008-05-15	Impfstoff gegen pferdeherpesvirus
IL179138A0 (en)	2007-03-08	Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31,45, or 52
SI1572233T1 (sl)	2011-07-29	Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68
EP1539938A4 (en)	2007-11-28	CHIMERIC GB-VIRUS B (GBV-B)
ATE346870T1 (de)	2006-12-15	Natürlicher antikörper mit wirkung gegen das hiv virus
CY2015049I2 (el)	2016-06-22	Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52
HK1103634A (en)	2007-12-28	Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
RU2003129439A (ru)	2005-04-10	2`-амино-2`-дезоксинуклеозиды-ингибиторы репродукции вирусов кори и марбург
AU2002242014A1 (en)	2002-09-24	Avian vaccine effective against infectious bursal disease virus
EP1483377A4 (en)	2005-03-30	VIRUS RECOVERY
IL184545A0 (en)	2007-10-31	Virus recovery medium, use thereof and viral diagnostic kit including same